EUVIMEDEUVIMED entdecken
Editorial

Is it time to start to consider treating the liver in glutaric aciduria type 1?

Sander Houten, Curtis R Coughlin

Journal of Inherited Metabolic Disease · 2023

DOI: 10.1002/jimd.12623 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Inherited Metabolic Disease, 2023. Verfasst von Sander Houten und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Brain Diseases, Metabolic. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acid Metabolism, Inborn ErrorsBrain Diseases, MetabolicLiverGlutaratesGlutaryl-CoA DehydrogenaseHumans

Substanzen

Glutaryl-CoA DehydrogenaseGlutarates

Autor:innen und Institutionen

  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Section of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Zitieren

APA

Houten, S., & Coughlin, C. R. (2023). Is it time to start to consider treating the liver in glutaric aciduria type 1?. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12623

Vancouver

Houten S, Coughlin CR. Is it time to start to consider treating the liver in glutaric aciduria type 1?. Journal of Inherited Metabolic Disease. 2023. doi:10.1002/jimd.12623

BibTeX
@article{Houten2023,
  author = {Houten, Sander and Coughlin, Curtis R},
  title = {Is it time to start to consider treating the liver in glutaric aciduria type 1?},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2023},
  doi = {10.1002/jimd.12623}
}
Kostenlos starten →